Showing results (411-420 of 420) with videos related to
Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 420 results.
Arthritis and Rheumatism|August 1, 1980
Metabolism of C4 and factor B in rheumatoid arthritis. Relation to rheumatoid factorR A Kaplan, J G Curd, D H Deheer, et al.Clinical and Experimental Immunology|August 10, 2000
Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA)M A Friese, J Hellwage, T S Jokiranta, et al.Journal of Lipid Research|June 5, 1999
Transgenic mice expressing a human apolipoprotein[a] alleleF Acquati, R Hammer, B Ercoli, et al.American Journal of Human Genetics|February 1, 1994
Clinical heterogeneity within xeroderma pigmentosum associated with mutations in the DNA repair and transcription gene ERCC3W Vermeulen, R J Scott, S Rodgers, et al.British Journal of Haematology|May 1, 2001
Drug monitoring of low-dose PEG-asparaginase (Oncaspar) in children with relapsed acute lymphoblastic leukaemiaJ P Vieira Pinheiro, H J Müller, D Schwabe, et al.British Journal of Haematology|March 2, 1999
Pharmacokinetic dose adjustment of Erwinia asparaginase in protocol II of the paediatric ALL/NHL-BFM treatment protocolsJ P Vieira Pinheiro, E Ahlke, U Nowak-Göttl, et al.British Journal of Haematology|June 10, 2000
Asparagine synthetase activity in paediatric acute leukaemias: AML-M5 subtype shows lowest activityA Dübbers, G Würthwein, H J Müller, et al.British Journal of Haematology|November 25, 2003
Pegylated asparaginase in combination with high-dose methotrexate for consolidation in adult acute lymphoblastic leukaemia in first remission: a pilot studyO Rosen, H J Müller, N Gökbuget, et al.British Journal of Haematology|September 6, 2000
Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocolsH J Müller, L Löning, A Horn, et al.British Journal of Haematology|September 21, 2001
Pharmacokinetics of native Escherichia coli asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL-BFM 95 reinduction treatmentH J Müller, R Beier, L Löning, et al.Pageof 42